Intervention Review

You have free access to this content

Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers

  1. Miranda van Rijen1,*,
  2. Marc Bonten2,
  3. Richard Wenzel3,
  4. Jan Kluytmans1

Editorial Group: Cochrane Wounds Group

Published Online: 8 OCT 2008

Assessed as up-to-date: 26 SEP 2010

DOI: 10.1002/14651858.CD006216.pub2


How to Cite

van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD006216. DOI: 10.1002/14651858.CD006216.pub2.

Author Information

  1. 1

    Amphia Hospital Breda, Laboratory for Microbiology and Infection Control, Breda, Netherlands

  2. 2

    University Medical Center Utrecht, Department of Internal Medicine and Infectious Diseases, Utrecht, Netherlands

  3. 3

    Virginia Commonwealth University, Department of Internal Medicine, Richmond, Virginia, USA

*Miranda van Rijen, Laboratory for Microbiology and Infection Control, Amphia Hospital Breda, PO Box 90158, Breda, 4800 RK, Netherlands. Mvrijen@amphia.nl.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 8 OCT 2008

SEARCH

  1. You have free access to this content

    Current Version

    Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers

    Miranda van Rijen, Marc Bonten, Richard Wenzel and Jan Kluytmans

    Article first published online: 8 OCT 2008 | DOI: 10.1002/14651858.CD006216.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers

    MML van Rijen, MJM Bonten, JAJW Kluytmans, RA Weinstein and RP Wenzel

    Article first published online: 18 OCT 2006 | DOI: 10.1002/14651858.CD006216